Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

SEPTEMBER 21, 2021

He also is a member of the Board of Directors at the Bend Chamber of Commerce and the Chamber’s Advocacy Committee. If we are going to provide medicinal cannabis opportunities covered by insurance, we need the ability to go through clinical trials and testing.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

The Cannigma

DECEMBER 22, 2021

Sometimes I have the sense that it’s like, every new state, or every new country that opens up a medical program, and then a recreational program just starts from scratch, as though there’s nothing we could learn. EG: Do you think there’s any good models around the world that we could be following?

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. He is an outspoken commentator on Climate Change and Security using community advocacy to raise awareness of the potential costs of inaction.

Medicine 52

Medicine Therapy Research and Development Business 52

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 119

Research and Development Education Agriculture Patients 119

Otherside Farms

JANUARY 25, 2019

Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.

Patients 76

Patients Clinical Trials Marijuana Policy 76

Cannabis Law Report

SEPTEMBER 23, 2022

SB 57 – which passed both houses – would have created a pilot program for overdose prevention sites in San Francisco, Oakland, and Los Angeles as an evidence-based intervention to curb drug overdose deaths. Policy and Advocacy Director, MAPS . Ismail Lourido Ali, J.D. ABOUT MAPS.

Decriminalization 52

Decriminalization Advocacy Research and Development Clinical Trials 52

Cannabis Law Report

AUGUST 25, 2022

The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. Policy and Advocacy Director, MAPS. In addition to the clinical research program to make MDMA into an FDA-approved medicine, MAPS was founded to create sensible and compassionate alternatives to the War on Drugs. Ismail L Ali, J.D.,

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

The Cannigma

MAY 7, 2021

Europe’s obviously come a long way and most of the countries on the continent have varying degrees of medical programs alongside going hemp industries but can you start by giving a quick overview of where Europe is in comparison to North America but also your thoughts on why the momentum seems to be different?

Supply Chain 119

Supply Chain Patients Access Hemp 119

SMPL

MAY 26, 2020

Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. Along with Representative Jared Polis, now the governor of Colorado, Mr. McConnell included a hemp pilot program in the 2014 farm bill — for “research.”

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. Kevin O’Leary.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. A 2016 study published in the Journal of School Health concluded alcohol use should be a target of school abuse prevention programs.

Data 191

Data Clinical Trials Chronic Pain Medicine 191